FDA Approves Adcetris® in Combination with Chemotherapy for Previously Untreated Stage III or IV Classical Hodgkin Lymphoma

CancerConnect News The US Food and Drug Administration FDA has approved Adcetris brentuximab vedotin in combination with chemotherapy in adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma The approval is based on the succe [...]